policy
Aminoglycoside use in cattle and small ruminants
The AVMA does not support extralabel use of aminoglycosides in cattle or small ruminants due to the substantial risk for violative residues in food…
policy
Assessment of new therapies for alleviation of pain in animals
Assessing the efficacy of analgesics used in veterinary clinical practice requires well-designed and appropriately controlled experimental clinical…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Notification to the veterinarian of violative residues in foods of animal origin
Veterinarians have an essential role in preventing such violations and ensuring the appropriate and judicious use of pharmaceuticals on food animal…
policy
Organic foods
Food producers should be encouraged to provide medically necessary therapy, including antimicrobials, under a veterinarian’s direction, regardless of…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Safety testing
The AVMA supports research to discover and develop safe and efficacious drugs, vaccines, biologicals, and medical devices that benefit animals and…
policy
Support for the collection of antimicrobial use data for antimicrobial stewardship
Antimicrobials are necessary tools for protecting animal health and wellbeing. Antimicrobial stewardship is successful only when all partners involved…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…